We are live on ! Find out more
QC

Quadrature Capital Portfolio holdings

AUM $11.7B
1-Year Est. Return 87.29%
This Fund
S&P 500
This Quarter Est. Return
+15.89%
1 Year Est. Return
+87.29%
3 Year Est. Return
+211.84%
5 Year Est. Return
+162.22%
10 Year Est. Return
+656.25%
AUM
$8.45B
AUM Growth
+$2.65B
Cap. Flow
+$1.84B
Cap. Flow %
21.75%
Top 10 Hldgs %
27.48%
Holding
1,605
New
606
Increased
210
Reduced
176
Closed
612

Top Buys

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$206M
2
TD icon
Toronto Dominion Bank
TD
+$181M
3
TSLA icon
Tesla
TSLA
+$177M
4
NFLX icon
Netflix
NFLX
+$173M
5
CRWV
CoreWeave
CRWV
+$172M

Sector Composition

Rank Sector Weight
1 Technology 27.44%
2 Financials 16.45%
3 Consumer Discretionary 10.88%
4 Industrials 7.86%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTL icon
651
Vertical Aerospace
EVTL
$115M
$322K ﹤0.01%
+62,350
New +$347K
ISTR icon
652
Investar Holding Corp
ISTR
$411M
$322K ﹤0.01%
+13,838
New +$311K
IIPR icon
653
Innovative Industrial Properties
IIPR
$1.66B
$319K ﹤0.01%
+5,968
New +$324K
MCRI icon
654
Monarch Casino & Resort
MCRI
$2.17B
$318K ﹤0.01%
+3,004
New +$301K
UAA icon
655
Under Armour
UAA
$2.5B
$317K ﹤0.01%
63,329
-27,603
-30% -$161K
SRFM icon
656
Surf Air Mobility
SRFM
$94.4M
$316K ﹤0.01%
+73,422
New +$344K
ARTNA icon
657
Artesian Resources
ARTNA
$357M
$314K ﹤0.01%
+9,647
New +$320K
SARK icon
658
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$39.5M
$312K ﹤0.01%
+10,868
New +$356K
CIG icon
659
CEMIG Preferred Shares
CIG
$5.84B
$310K ﹤0.01%
+147,832
New +$290K
LXRX icon
660
Lexicon Pharmaceuticals
LXRX
$1.07B
$309K ﹤0.01%
+228,209
New +$259K
NPK icon
661
National Presto Industries
NPK
$985M
$309K ﹤0.01%
+2,762
New +$293K
INGR icon
662
Ingredion
INGR
$6.53B
$308K ﹤0.01%
2,522
-3,658
-59% -$471K
CPT icon
663
Camden Property Trust
CPT
$11B
$308K ﹤0.01%
+2,885
New +$317K
HURN icon
664
Huron Consulting
HURN
$2.42B
$308K ﹤0.01%
+2,097
New +$286K
GLIBK
665
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.01B
$307K ﹤0.01%
+8,234
New +$290K
LCTX icon
666
Lineage Cell Therapeutics
LCTX
$286M
$304K ﹤0.01%
+179,031
New +$212K
RNG icon
667
RingCentral
RNG
$5.38B
$303K ﹤0.01%
+10,697
New +$312K
TNGX icon
668
Tango Therapeutics
TNGX
$4.51B
$303K ﹤0.01%
+36,189
New +$245K
CLMB icon
669
Climb Global Solutions
CLMB
$506M
$301K ﹤0.01%
8,940
-15,572
-64% -$462K
KBDC
670
Kayne Anderson BDC
KBDC
$927M
$301K ﹤0.01%
+22,659
New +$344K
AMRN
671
Amarin Corp
AMRN
$298M
$300K ﹤0.01%
+18,346
New +$285K
HURC icon
672
Hurco Companies Inc
HURC
$141M
$299K ﹤0.01%
+17,222
New +$318K
FSBW icon
673
FS Bancorp
FSBW
$316M
$299K ﹤0.01%
+7,473
New +$307K
SAIC icon
674
Saic
SAIC
$5.3B
$297K ﹤0.01%
2,991
-9,193
-75% -$1.03M
EXAS
675
DELISTED
Exact Sciences
EXAS
$295K ﹤0.01%
+5,390
New +$269K

Similar funds

Quadrature Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Quadrature Capital held 1,605 positions worth $8.45B, up 46% from $5.81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Quadrature Capital deployed $1.84B of net new capital in Q3 2025, opening 606 new positions and adding to 210 existing holdings. Its largest new stake was Tesla: 510,127 shares worth $227M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $199M trimmed.

  • Quadrature Capital's largest Q3 2025 buy was Tesla: 510,127 shares worth $227M.
  • Quadrature Capital added most to Royal Bank of Canada in Q3 2025, an estimated $206M increase.
  • Quadrature Capital's biggest Q3 2025 reduction was Apple, cutting an estimated $199M.
  • Quadrature Capital fully exited UnitedHealth in Q3 2025, selling an estimated $177M.
  • Quadrature Capital's ten largest holdings make up 27% of its $8.45B portfolio in Q3 2025.
  • Quadrature Capital opened 606 new positions and closed 612 in Q3 2025.
  • Quadrature Capital's portfolio value rose 46% quarter-over-quarter to $8.45B.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.